Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedThe site revision displayed on the 403 Forbidden error page changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows a 403 Forbidden error, blocking access to the study record; the usual study content and navigation are replaced by an access-denied message.SummaryDifference18%

- Check27 days agoChange DetectedThe page now shows a new site revision label, Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an update to the page framework or template that does not affect the study content or eligibility details.SummaryDifference0.0%

- Check41 days agoChange DetectedFooter revision label updated to v3.6.6, replacing the prior v3.6.5. This reflects a minor site maintenance update to the page metadata.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This appears to be a minor template/metadata change that does not modify study content or outcomes.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a small update to the study record page. The change affects only metadata and does not modify the study content.SummaryDifference0.0%

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.